Search clinical trials for: Capmatinib (INC280)
Total 910 results
-
Beijing Sanbo Brain HospitalRecruitingRecurrent Atypical/Malignant MeningiomaChina
-
Affiliated Hospital of Qinghai UniversityCompleted
-
The Affiliated Hospital of Qingdao UniversityUnknown
-
Jiangsu HengRui Medicine Co., Ltd.UnknownSubjects With Impaired Renal Function and Healthy Subjects
-
Jiangsu HengRui Medicine Co., Ltd.Fudan University; The 81 Hospital of PLACompletedAdvanced or Metastatic Gastric CancerChina
-
Beijing Chest HospitalNot yet recruiting
-
Henan Cancer HospitalRecruitingCamrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer (CAMERA)Small Cell Lung CarcinomaChina
-
Sun Yat-sen UniversityRecruitingNeoadjuvant Therapy | Apatinib | Carilizumab | Recurrent High-Grade GliomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.CompletedToxicity | Effect of Drug | DrugChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
Shanghai Zhongshan HospitalUnknownGastric Cancer | Chemotherapy Effect | Chemotherapeutic ToxicityChina
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
The Affiliated Hospital of the Chinese Academy...Unknown
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHead and Neck Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastSpain, Canada, United States, Australia, Austria, Italy, Japan, Poland, Sweden, France, Germany, Switzerland, Taiwan, United Kingdom, Belgium, Greece, India
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Netherlands
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
Georgetown UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
GlaxoSmithKlineCompletedMetastatic Cervical Cancer | Neoplasms, Uterine CervixUnited States, Germany, Spain, Thailand, Belgium, Italy, Argentina, Canada, Ireland, India, France, Estonia, Mexico
-
Institute of Cancer Research, United KingdomGlaxoSmithKlineCompletedBreast CancerUnited Kingdom
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastCanada, Netherlands, United States, Spain, Korea, Republic of
-
Xuanwu Hospital, BeijingRecruitingChordoma | Chemotherapy EffectChina
-
Ruijin HospitalRecruiting
-
Sun Yat-sen UniversityCompletedRecurrent Cervical Carcinoma | Metastatic Cervical CancerChina
-
First Affiliated Hospital Bengbu Medical CollegeUnknownGastric Cancer | Apatinib | BiomarkerChina
-
Tongji UniversityUnknownNon-small Cell Lung CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Jiangsu HengRui Medicine Co., Ltd.Unknown
-
University of Wisconsin, MadisonGlaxoSmithKlineCompletedMetastatic Colorectal CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Zhejiang UniversityRecruitingHepatocellular CarcinomaChina
-
Sun Yat-sen UniversityActive, not recruitingNasopharyngeal Carcinoma | Chemotherapy Effect | Immunotherapy | Recurrent Nasopharyngeal Carcinoma | Metastatic Nasopharyngeal Carcinoma | Molecular Targeted TherapyChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHepatocellular CarcinomaChina
-
Hubei Cancer HospitalEnrolling by invitation
-
Peking University Cancer Hospital & InstitutePeking University First Hospital; Shanxi Province Cancer Hospital; Peking University... and other collaboratorsCompleted
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.CompletedIntrahepatic Cholangiocarcinoma | Second-line TreatmentChina
-
Qianfoshan HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.UnknownImmune Checkpoint InhibitionChina
-
Henan Cancer HospitalUnknownAdvanced Gastric Cancer
-
GUO WEICompletedOsteosarcoma | MetastasisChina
-
Tianjin Medical University Cancer Institute and...Zhejiang Cancer Hospital; Fudan University; Liaoning Tumor Hospital & Institute; Gansu Cancer HospitalUnknownSoft Tissue Sarcoma, Adult, Stage IIChina
-
Hebei Medical University Fourth HospitalRecruiting
-
Qilu Hospital of Shandong UniversityNot yet recruiting
-
Xiaohua Wu MDNot yet recruitingRelapsed Ovarian Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingStage III Hepatocellular Cancer (CNLC Staging)China
-
Hunan Cancer HospitalJiangsu Hengrui Pharmaceuticals Co.,LtdRecruitingHepatocellular Carcinoma | Immune Checkpoint InhibitorsChina
-
Peking University First HospitalNot yet recruiting
-
The First Affiliated Hospital of Xiamen UniversityNot yet recruitingProgression-free Survival;Progression-free Survival;Disease Control Rate; SafetyChina